What 21 CFR Part 58, FDA's good laboratory practice rule for nonclinical laboratory studies, requires: subparts A to K, the study director (58.33), the quality assurance unit (58.35), protocol and final report content, and record retention (58.195). Includes a GLP vs GMP comparison, the status of FDA's 2016 proposed GLP rule, and Atlas data on 30 Form 483s that cited Part 58 from January 2025 to June 2026 plus six GLP warning letters.